Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Part, Randomized Study of Dermacyte® Amniotic Wound Care Matrix for the Treatment of Diabetic Foot Ulcers (DFU)

NCT06444906 is registered in ClinicalTrials.gov with Merakris Therapeutics as lead sponsor.

NCT NCT06444906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06444906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Part, Randomized Study of Dermacyte® Amniotic Wound Care Matrix for the Treatment of Diabetic Foot Ulcers (DFU)
Lead sponsor
Merakris Therapeutics
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2024
Completion date
May 31, 2025
Enrollment
85 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer